DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Négrier S.
Better survival with interleukin-2-based regimens? Possibly only in highly selected patients.
J Clin Oncol 2004; 22: 1174-1176
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.